Our company: UCB Canada
Dedicated to making an impact where it matters most
At UCB Canada, our unique position as a mid-sized pharmaceutical company with a global reach enables our team members to make a tangible impact. We foster a collaborative environment where every contribution is crucial, driving advancements in dermatology, neurology, rheumatology and the treatment of inflammatory disorders and rare diseases.
We invite you to join us in this dynamic setting where innovative ideas of each employee are essential to our entrepreneurial spirit and commercial success. UCB Canada presents an opportunity to stretch your capabilities, intertwining deep scientific understanding, such as the complexities of monoclonal antibodies, with the intricacies of marketing and the supply chain to deliver life-changing solutions. Your vision can help improve the lives of our patients.
Our purpose: Delivering valuable health solutions
At UCB, our global mission is clear:
we channel significant R&D investments and embrace technological and scientific breakthroughs to create impactful solutions for severe diseases. Our strategic focus is on delivering real value guided by patients' needs. This sets us apart with purposeful innovation and fortifies our commitment to improving lives in the present and future.
As responsible leaders in healthcare, we engage in a broader dialogue that prioritizes often-overlooked health needs. We’re constantly returning to the fundamental question that drives us: "How can we create more value for people living with severe diseases?" This guiding principle shapes every step we take and every solution we provide.
Person-focused, people-driven
Meeting patients’ unmet needs
Even though our medicines benefit thousands of patients globally, our mission is far from complete.
- We must listen to the needs of patients and their families
- By collaborating with physicians and other healthcare professionals, we provide patients with a better understanding of their clinical, financial, social and personal needs
- What matters most is how people feel in their everyday lives as they progress on their healthcare journey. This is because we’re not just treating a disease—we’re caring for individuals
Patients inspire us to create value through cutting-edge science, innovative drugs and practical solutions so that they and their caregivers can thrive.
Continuously advancing science and personalizing treatment
At UCB, we recognize that each patient is unique: we believe in personalized healthcare. We are committed to meaningful science that incorporates the specific needs of patient populations into our innovation process. By harnessing advancements in genetics, biomarkers and human biology, we deepen our understanding of disease variations and patient experiences to deliver tailored drugs and care. Our teams are dedicated to matching the right treatment to the right patient.
UCB in Canada:
A history of innovation
Since 2006, UCB Canada has upheld a tradition of supporting innovative patient and healthcare programs centered on patient care. We proudly back Canadian research and have enabled over 6,000 Canadians to partake in global clinical trials. This commitment reinforces our dedication to advancing treatments in neurology and immunology, enriching patients’ lives nationwide.
Facts and figures
- UCB Canada Inc. was established in 2006
- UCB Canada's head office is located in Oakville, Ontario, with a dedicated team across the country
- UCB Canada Inc. is a proud member of BIOTECanada, representing Canada's health, industrial and agricultural biotechnology sectors
- In 2024, UCB Canada joined Innovations Medicines Canada (IMC) as a full-time member to join other partners in championing policies to drive discovery, innovation and to work together to transform Canadians' lives through timely access to world-class innovative medicines
Global Expertise:
Renowned for world-class expertise in central nervous system diseases, immunology and rare diseases
Global Presence:
Founded in 1928, headquartered in Brussels, Belgium, with operations in approximately 40 countries and a workforce of over 9,000 employees worldwide
Responsibility
UCB prioritizes safety and efficacy and is dedicated to creating therapies that address rare diseases' physical and social impacts. Embracing a patient-centric culture, we support patients, families, caregivers and physicians by providing personalized, transformational treatments and resources to aid their treatment journey. This holistic approach is crucial to our innovation and commitment to improving patient care.
UCB is firmly committed to minimizing our environmental footprint, both within our operations and alongside our partners. Focused on innovative sustainability practices, we aim to conserve natural resources, protect air quality and reduce waste. Honoured by Corporate Knights as one of the World's Most Sustainable Companies, we're also globally engaged in reducing our carbon emissions. Our dedication to corporate and social responsibility is detailed in our latest Corporate Sustainability Reporting Directive (CSRD) report, which is part of our 2023 Annual Report and accessible online.
UCB Canada’s main sustainable performance priorities have been identified as the following: Sustainable Access to our product by our patients; Our employees; Health, Safety and Wellbeing; Preserving our environment; and Engaging with patients, their caregivers, and healthcare professionals to understand their needs and provide value through sustainable solutions. Each of these priorities has clearly defined metrics to measure and record our performance and to track our impact. An example of such metrics is the kgCO2 that we generate in Canada. Through continuous awareness and optimization of our travel habits and impact of our operations, we have successfully reduced our carbon footprint to 40% below pre-pandemic levels (2019). UCB Canada remains committed to further reductions as we align with UCB’s Environmental Goals for 2030. For more information, please review UCB Global for further details.
Sustainability remains embedded in UCB Canada’s strategic ambition and forms a fundamental part of our vision for the future.
UCB has a rich pipeline of research underway. Please visit our global website to learn more about our efforts and medications in development.
